Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2021; 13(03): 252-256
DOI: 10.1055/s-0041-1731106
Original Article

Nitrofurantoin Susceptibility Pattern in Gram-Negative Urinary Isolates: In Need of Increased Vigilance

Garima Gautam
1   Department of Microbiology, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India
,
Sanjib Gogoi
1   Department of Microbiology, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India
,
Sonal Saxena
2   Department of Microbiology, Maulana Azad Medical College and Associated Hospitals, New Delhi, India
,
Ravinder Kaur
1   Department of Microbiology, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India
,
Megh Singh Dhakad
1   Department of Microbiology, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

Nitrofurantoin is the first-line drug in the treatment of uncomplicated urinary tract infections (UTIs) and its use has increased exponentially in recent years.

Objectives This study aims to determine the susceptibility pattern of nitrofurantoin in gram-negative urinary isolates and to evaluate their bacteriological and epidemiological profile along with co-existing resistance to other important urinary antimicrobials.

Material and Methods This was a retrospective study conducted in a tertiary care hospital in New Delhi in which 500 gram-negative bacterial urinary isolates were evaluated. Records of antimicrobial susceptibility were reviewed from July to September 2019. Antimicrobial susceptibility was performed using the Kirby–Bauer disk diffusion method on Mueller Hinton agar and interpreted using CLSI 2019. Test for extended spectrum β-lactamase (ESBL) producers was done using double disk approximation test.

Statistical Analysis Data analysis was performed using the SPSS windows version 25.0 software.

Results Out of total 500 isolates, 20.17% (94) isolates were resistant (R) to nitrofurantoin and 9.01% (42) were found to be intermediate (I). Highest resistance was seen in Klebsiella sp. (44.61%) and Escherichia coli (8.12%). About 28.82% of the I/R isolates were of the pediatrics age group and most of the isolates belonged to females (64.69%). High resistance was also seen against ampicillin (92.30%), cefazolin (88.46%), ceftazidime (73.0%), and fluoroquinolones (65.38%). Carbapenemase co-resistance was seen in 57.15% isolates whereas ESBL production was seen in 30.76% of E. coli and 12.06% of Klebsiella sp.

Conclusion Increase in multidrug resistance uropathogens along with a near absence of novel oral antibiotics has led to increased consumption of nitrofurantoin since its resistance has increased.

Keywords

nitrofurantoin - disk diffusion - antimicrobial susceptibility - gram-negative bacteria


Publication History

Article published online:
06 July 2021

© 2021. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Amladi AU, Abirami B, Devi SM. et al Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections. Indian J Med Res 2019; 149 (02) 185-191
    CrossrefPubMedGoogle Scholar
  • 2 Kahlmeter G. ECO.SENS. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 2003; 51 (01) 69-76
    CrossrefPubMedGoogle Scholar
  • 3 Singh RM, Devi MU, Singh KL, Singh HL, Keisham C, Singh KH. Evaluation of nitrofurantoin activity against the urinary isolates in the current scenario of antimicrobial resistance. Ann Trop Med Public Health 2015; 8 (06) 280-285
    CrossrefGoogle Scholar
  • 4 Shakti L, Veeraraghavan B. Advantage and limitations of nitrofurantoin in multi-drug resistant Indian scenario. Indian J Med Microbiol 2015; 33 (04) 477-481
    CrossrefPubMedGoogle Scholar
  • 5 Munoz-Davila MJ. Role of old antibiotics in the era of antibiotic resistance. Highlighted nitrofurantoin for the treatment of lower urinary tract infections. Antibiotics (Basel) 2014; 3 (01) 39-48
    CrossrefPubMedGoogle Scholar
  • 6 Jorgensen J. Manual of Clinical Microbiology. 11th ed.. Washington, DC: American Society of Microbiology; 2015
    CrossrefGoogle Scholar
  • 7 Gupta V, Yadav A, Joshi RM. Antibiotic resistance pattern in uropathogens. Indian J Med Microbiol 2002; 20 (02) 96-98
    PubMedGoogle Scholar
  • 8 Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Int J Infect Dis 2009; 13 (02) 140-144
    CrossrefPubMedGoogle Scholar
  • 9 Patel HB, Soni ST, Bhagyalaxmi A, Patel NM. Causative agents of urinary tract infections and their antimicrobial susceptibility patterns at a referral center in Western India: an audit to help clinicians prevent antibiotic misuse. J Family Med Prim Care 2019; 8 (01) 154-159
    CrossrefPubMedGoogle Scholar
  • 10 Shaifali I, Gupta U, Mahmood SE, Ahmed J. Antibiotic susceptibility patterns of urinary pathogens in female outpatients. N Am J Med Sci 2012; 4 (04) 163-169
    CrossrefPubMedGoogle Scholar
  • 11 Sood S, Gupta R. Antibiotic resistance pattern of community acquired uropathogens at a tertiary care hospital in Jaipur, Rajasthan. Indian J Community Med 2012; 37 (01) 39-44
    CrossrefPubMedGoogle Scholar
  • 12 Gupta K, Hooton TM, Naber KG. et al Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52 (05) e103-e120
    CrossrefPubMedGoogle Scholar
  • 13 Badhan R, Singh DV, Badhan LR, Kaur A. Evaluation of bacteriological profile and antibiotic sensitivity patterns in children with urinary tract infection: a prospective study from a tertiary care center. Indian J Urol 2016; 32 (01) 50-56
    CrossrefPubMedGoogle Scholar
  • 14 Sanchez GV, Master RN, Karlowsky JA, Bordon JM. In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrob Agents Chemother 2012; 56 (04) 2181-2183
    CrossrefPubMedGoogle Scholar
  • 15 Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. Int J Antimicrob Agents 2012; 39 (01) 45-51
    CrossrefPubMedGoogle Scholar
  • 16 Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, Mouton JW. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother 2015; 70 (09) 2456-2464
    CrossrefPubMedGoogle Scholar
  • 17 Sandegren L, Lindqvist A, Kahlmeter G, Andersson DI. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J Antimicrob Chemother 2008; 62 (03) 495-503
    CrossrefPubMedGoogle Scholar
  • 18 Ho P-L, Ng K-Y, Lo W-U. et al Plasmid-mediated OqxAB is an important mechanism for nitrofurantoin resistance in Escherichia coli. Antimicrob Agents Chemother 2015; 60 (01) 537-543
    PubMedGoogle Scholar
  • 19 Osei Sekyere J. Genomic insights into nitrofurantoin resistance mechanisms and epidemiology in clinical Enterobacteriaceae . Future Sci OA 2018; 4 (05) FSO293
    CrossrefPubMedGoogle Scholar
  • 20 Kulkarni SR, Peerapur BV, Sailesh KS. Isolation and antibiotic susceptibility pattern of Escherichia coli from urinary tract infections in a Tertiary Care Hospital of North Eastern Karnataka. J Nat Sci Biol Med 2017; 8 (02) 176-180
    CrossrefPubMedGoogle Scholar
  • 21 Kothari A, Sagar V. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. J Infect Dev Ctries 2008; 2 (05) 354-358
    CrossrefPubMedGoogle Scholar
  • 22 Suresh A. Antibiotic resistance pattern in urinary tract infection during pregnancy in South Indian population. Asian J Pharm 2018;12(2)